Stocks › AHCO
AdaptHealth AHCO
US equityMarket cap rank #3177
$7.20 −$0.05 (-0.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.20 0.00%
Open$7.25
Prev close$7.25
Day range$7.15 – $7.42
Volume1.07M
Market cap$982.98M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$568.33M+13.7% YoY
Operating profit$16.83M-61.2% YoY
Net profit-$152.77M-693.3% YoY
Diluted EPS-$1.13-764.7% YoY
Free cash flow$51.06M-23.6% YoY
Operating cash flow$156.59M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin15.3%
Operating margin3.1%
Net margin-11.9%
Return on equity-28.6%
Return on assets-9.5%
Return on invested capital-9.1%
Current ratio1.13
Liabilities / assets70.6%
Cash & investments$80.69M
Total debt$2.00B
Net cash (debt)-$1.91B
Free cash flow / sales2.4%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $745.65M | $740.31M | $819.80M | $3.24B | $1.27B |
| Total Operating Revenue | $568.33M | $567.53M | $614.32M | $3.24B | $1.76B |
| Cost of Revenue | $630.84M | $636.10M | $708.30M | $2.64B | $1.04B |
| Gross Profit | -$62.51M | -$68.57M | -$93.98M | $609.20M | $722.07M |
| Operating Expense | -$79.34M | -$68.73M | -$99.47M | $422.93M | $626.06M |
| Selling and Admin Expenses | $88.66M | $96.09M | $95.91M | $382.29M | $113.99M |
| -General & Admin Expense | $88.66M | $96.09M | $95.91M | $382.29M | $113.99M |
| Depreciation & Amortization & Depletion | $9.32M | $7.95M | $10.10M | $40.64M | $19.31M |
| -Depreciation & Amortization | $9.32M | $7.95M | $10.10M | $40.64M | $19.31M |
| Other Operating Expenses | -$177.32M | -$172.77M | -$205.48M | – | – |
| Operating Profit | $16.83M | $165,000.00 | $5.49M | $186.27M | $96.01M |
| Net Non-Operating Interest Income (Expense) | -$28.60M | -$26.21M | -$25.59M | -$105.75M | -$24.44M |
| Non-Operating Interest Expense | $28.60M | $26.21M | $25.59M | $105.75M | $24.44M |
| Other Income (Expense) | -$172.75M | -$139.29M | – | -$95.67M | -$127.89M |
| Special Income (Charges) | -$172.75M | -$139.29M | – | -$95.39M | -$127.62M |
| -Less:Impairment of Capital Assets | $184.75M | $144.24M | – | $128.00M | $128.00M |
| -Gain on Sale Of Business | $12.00M | $6.27M | – | $32.60M | $377,000.00 |
| Pretax Profit | -$184.52M | -$165.33M | -$20.11M | -$15.15M | -$56.32M |
| Tax | -$17.49M | -$21.23M | -$5.23M | $50.88M | $14.07M |
| Net Profit | -$152.77M | -$132.72M | -$14.87M | -$66.04M | -$101.54M |
| Profit from Continuing Operations | -$167.03M | -$144.11M | -$14.87M | -$66.04M | -$70.39M |
| Net Income from Discontinuous Operations | $14.26M | $11.39M | – | – | – |
| Minority Interests | $1.22M | $1.21M | $1.17M | $4.76M | $1.23M |
| Net Income to Parent Company | -$153.99M | -$133.93M | -$16.04M | -$70.79M | -$102.77M |
| Net Income to Common Stockholders | -$153.99M | -$133.93M | -$16.04M | -$70.79M | -$102.77M |
| Basic EPS | -$1.13 | -$0.99 | -$0.12 | -$0.52 | -$0.76 |
| Diluted EPS | -$1.13 | -$0.99 | -$0.12 | -$0.52 | -$0.76 |
| -Less:Other Special Charges | – | $1.32M | – | – | – |
| Other Non-Operating Income (Expenses) | – | – | – | -$274,000.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $4.20B | $4.34B | $4.42B | $4.32B | $4.32B |
| Total Current Assets | $839.09M | $797.48M | $687.48M | $728.90M | $728.90M |
| Cash and Cash Equivalents & Short-Term Investments | $80.69M | $43.29M | $47.96M | $106.14M | $106.14M |
| -Cash and Cash Equivalents | $80.69M | $43.29M | $47.96M | $106.14M | $106.14M |
| Receivables | $395.87M | $390.39M | $391.97M | $370.90M | $370.90M |
| -Accounts Receivable | $395.87M | $390.39M | $391.97M | $370.90M | $370.90M |
| Inventory | $111.90M | $105.48M | $159.27M | $151.25M | $151.25M |
| Other Current Assets | $73.51M | $90.22M | $88.28M | $100.62M | $100.62M |
| Total Non-Current Assets | $3.36B | $3.54B | $3.74B | $3.59B | $3.59B |
| Net PPE | $807.51M | $828.37M | $795.08M | $674.22M | $674.22M |
| -Gross PPE | $1.44B | $1.39B | $1.33B | $1.20B | $1.20B |
| -Accumulated Depreciation | -$629.81M | -$559.20M | -$536.16M | -$524.15M | -$524.15M |
| Goodwill and Other Intangible Assets | $2.19B | $2.40B | $2.65B | $2.63B | $2.63B |
| -Goodwill | $2.16B | $2.37B | $2.57B | $2.54B | $2.54B |
| -Other Intangible Assets | $29.90M | $31.78M | $80.23M | $85.12M | $85.12M |
| Non-Current Deferred Assets | $303.00M | $290.72M | $275.06M | $267.79M | $267.79M |
| Other Non-Current Assets | $62.90M | $22.09M | $18.80M | $19.12M | $19.12M |
| Total Liabilities | $2.97B | $2.95B | $2.91B | $2.79B | $2.79B |
| Total Current Liabilities | $744.82M | $709.21M | $743.29M | $712.39M | $712.39M |
| Payables | $443.77M | $389.52M | $431.95M | $352.38M | $352.38M |
| -Accounts Payable | $443.77M | $389.52M | $431.95M | $352.38M | $352.38M |
| Current Accrued Expenses | $141.13M | $137.06M | $120.14M | $151.52M | $151.52M |
| Short-Term Debt and Capital Lease Obligation | $71.07M | $63.49M | $78.27M | $68.74M | $68.74M |
| -Current Debt | $16.25M | $8.13M | $24.38M | $20.31M | $20.31M |
| -Current Capital Lease Obligation | $54.82M | $55.37M | $53.90M | $48.43M | $48.43M |
| Current Provisions | $15.77M | $49.72M | $49.30M | $49.80M | $49.80M |
| Current Deferred Liabilities | $67.18M | $64.74M | $59.73M | $59.84M | $59.84M |
| Other Current Liabilities | $5.89M | $4.68M | $3.89M | $30.11M | $30.11M |
| Total Non-Current Liabilities | $2.22B | $2.25B | $2.17B | $2.08B | $2.08B |
| Long Term Debt and Capital Lease Obligation | $1.98B | $2.00B | $1.92B | $1.83B | $1.83B |
| -Long Term Debt | $1.87B | $1.88B | $1.80B | $1.72B | $1.72B |
| -Long Term Capital Lease Obligation | $111.25M | $121.79M | $123.53M | $118.07M | $118.07M |
| Other Non-Current Liabilities | $243.81M | $243.81M | $243.81M | $243.80M | $243.80M |
| Total Equity | $1.23B | $1.39B | $1.51B | $1.53B | $1.53B |
| Stockholders' Equity | $1.23B | $1.38B | $1.51B | $1.52B | $1.52B |
| Capital Stock | $15,000.00 | $15,000.00 | $15,000.00 | $14,000.00 | $14,000.00 |
| -Common Stock | $14,000.00 | $14,000.00 | $14,000.00 | $13,000.00 | $13,000.00 |
| -Preferred Stock | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| Additional Paid-In Capital | $2.19B | $2.19B | $2.18B | $2.18B | $2.18B |
| Retained Earnings | -$936.93M | -$782.94M | -$649.01M | -$632.97M | -$632.97M |
| Less: Treasury Stock | -$25.55M | -$25.55M | -$25.55M | -$25.55M | -$25.55M |
| Gains/Losses Not Affecting Retained Earnings | $0.00 | $0.00 | $0.00 | $78,000.00 | $78,000.00 |
| Minority Interests | $7.54M | $7.79M | $7.41M | $7.76M | $7.76M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $156.59M | $145.30M | $93.72M | $601.77M | $183.18M |
| Net cash flow from continuing operations | $156.59M | $145.30M | $93.72M | $601.77M | $183.18M |
| Net Income from Continuing Operations | -$152.77M | -$132.72M | -$14.87M | -$66.04M | -$101.54M |
| Gain/Loss from Continuing Operations | -$12.00M | – | – | -$32.60M | -$377,000.00 |
| Depreciation & Depletion & Amortization | $116.90M | $120.30M | $106.47M | $381.93M | $97.51M |
| Deferred Tax | -$12.28M | -$15.55M | -$5.60M | $47.16M | -$4,000.00 |
| Other Non-Cash Items | $20.88M | $16.81M | $16.11M | $54.87M | $13.55M |
| Change in Working Capital | $11.12M | $11.12M | -$15.60M | $66.58M | $40.92M |
| -Change in Receivables | -$5.48M | $1.58M | -$21.07M | $30.99M | $8.84M |
| -Change in Inventory | -$17.01M | $19.82M | -$7.75M | -$11.49M | -$1.74M |
| -Change in Prepaid Assets | $16.70M | -$1.87M | $11.91M | -$61.07M | $13.99M |
| -Change in Other Current Liabilities | $16.91M | -$8.40M | $1.31M | $108.16M | $19.83M |
| Net cash flow from investing | -$107.53M | -$202.71M | -$204.46M | -$303.19M | -$124.47M |
| Net Cash Flow from Continuing Investing Activities | -$107.53M | -$202.71M | -$204.46M | -$303.19M | -$124.47M |
| Net PPE Purchase and Sale | -$105.53M | -$166.24M | -$121.21M | -$382.39M | -$103.90M |
| Net Business Purchase and Sale | -$2.00M | -$36.47M | -$84.68M | $78.04M | -$20.57M |
| Net Other Investing Changes | $0.00 | $0.00 | $1.44M | $1.16M | $0.00 |
| Financing Cash Flow | -$11.67M | $52.74M | $52.56M | -$302.19M | -$32.94M |
| Net Cash Flow from Continuing Financing Activities | -$11.67M | $52.74M | $52.56M | -$302.19M | -$32.94M |
| Net Issuance Payments Of Debt | -$9.84M | $59.05M | $82.83M | -$268.48M | -$31.30M |
| Proceeds from Stock Option Exercised | $387,000.00 | $487,000.00 | $464,000.00 | $1.21M | $1,000.00 |
| Net Other Financing Charges | -$2.22M | -$6.80M | -$30.74M | -$34.93M | -$1.64M |
| Ending Cash Balance | $80.69M | $43.29M | $47.96M | $106.14M | $106.14M |
| Net Change in Cash | $37.40M | -$4.68M | -$58.17M | -$3.61M | $25.78M |
| Beginning Cash Balance | $43.29M | $47.96M | $106.14M | $109.75M | $80.36M |
| Free Cash Flow | $51.06M | -$20.94M | -$27.49M | $219.38M | $79.29M |
| Net Investment Purchase and Sale | – | – | – | $0.00 | – |
| Net Common Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on AHCO.
Sign in to join the discussion.